文献速递中医内科中药与中成药合理使用

中药靶向TGF-β/Smad信号通路治疗肾纤维化的潜在策略

Traditional Chinese Medicine targeting the TGF-β/Smad signaling pathway as a potential therapeutic strategy for renal fibrosis.
PubMed 文献 · Front Pharmacol · 2025-05-20

肾纤维化是几乎所有进展性慢性肾脏病(CKD)的必然结局,但能阻止或逆转肾纤维化及CKD进展的有效疗法仍有限。本文综述了TGF-β/Smad信号通路在肾纤维化中的关键作用,并概述了通过调控该通路改善肾纤维化的单味中药、其活性成分及中药复方,旨在为肾纤维化领域未来基础与临床研究奠定基础。

要点

  • TGF-β/Smad通路是肾纤维化的关键信号通路,中药可靶向该通路发挥抗纤维化作用。
  • 综述汇总了单味中药、活性成分及中药复方通过调控TGF-β/Smad改善肾纤维化的证据。
  • 中药治疗肾纤维化有独特优势,但需解决质控、机制阐明与临床验证等局限。

核心结论

  • 中药通过抗氧化和抗炎药理特性,靶向TGF-β/Smad信号通路,展现出显著的抗肾纤维化潜力。

研究设计与样本

  • 综述类文献,按中药相关性清晰度筛选文献,涵盖中药类型与机制。

主要发现

  • TGF-β/Smad信号通路在肾纤维化中起关键作用。
  • 单味中药、其活性成分及中药复方可通过调控TGF-β/Smad通路改善肾纤维化。

临床怎么用

  • 中药可作为靶向TGF-β/Smad通路治疗肾纤维化的潜在策略,但需进一步研究验证。

局限性

  • 中药治疗肾纤维化存在局限性,需通过科学研究和科技创新解决机制阐明、质量控制及临床疗效验证等问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Renal fibrosis (RF) is an inevitable outcome of nearly all progressive chronic kidney diseases (CKD). However, effective therapies that can halt or reverse the development of RF and CKD progression remain limited. Traditional Chinese Medicine (TCM) offers a unique therapeutic approach, demonstrating significant anti-fibrotic potential through its antioxidant and anti-inflammatory pharmacological properties. However, comprehensive reviews focusing on the role of TCM in targeting signaling pathways associated with RF are still scarce. In this review, the literature was screened according to the clarity of the relevance of TCM, including the types and mechanisms of TCM. We summarize the pivotal role of the TGF-β/Smad signaling pathway in RF and provide an overview of single Chinese botanical drug, their active ingredients, and TCM compounds that ameliorate RF by modulating this pathway, aiming to establish a solid foundation for future basic and clinical research in the field of RF. While TCM holds unique advantages in treating RF, its limitations need to be addressed through scientific research and technological innovation. Future studies will focus on elucidating mechanisms, improving quality control, validating clinical efficacy, and fostering international collaboration to promote the scientific and global application of TCM in modern medicine.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Jiao H, Zhang M, Chen L, et al. Traditional Chinese Medicine targeting the TGF-β/Smad signaling pathway as a potential therapeutic strategy for renal fibrosis. Front Pharmacol. 2025. PMID: 40463902. doi:10.3389/fphar.2025.1513329

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。